Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

409 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Endpoint comparison for bone mineral density measurements in North Central Cancer Treatment Group cancer clinical trials N02C1 and N03CC (Alliance).
Dueck AC, Singh J, Atherton P, Liu H, Novotny P, Hines S, Loprinzi CL, Perez EA, Tan A, Burger K, Zhao X, Diekmann B, Sloan JA; Alliance for Clinical Trials in Oncology. Dueck AC, et al. Among authors: atherton p. Osteoporos Int. 2015 Jul;26(7):1971-7. doi: 10.1007/s00198-015-3091-4. Epub 2015 Mar 7. Osteoporos Int. 2015. PMID: 25749740 Free PMC article. Clinical Trial.
Evaluation of shark cartilage in patients with advanced cancer: a North Central Cancer Treatment Group trial.
Loprinzi CL, Levitt R, Barton DL, Sloan JA, Atherton PJ, Smith DJ, Dakhil SR, Moore DF Jr, Krook JE, Rowland KM Jr, Mazurczak MA, Berg AR, Kim GP; North Central Cancer Treatment Group. Loprinzi CL, et al. Among authors: atherton pj. Cancer. 2005 Jul 1;104(1):176-82. doi: 10.1002/cncr.21107. Cancer. 2005. PMID: 15912493 Free article. Clinical Trial.
A phase III randomized, double-blind, placebo-controlled trial of gabapentin in the management of hot flashes in men (N00CB).
Loprinzi CL, Dueck AC, Khoyratty BS, Barton DL, Jafar S, Rowland KM Jr, Atherton PJ, Marsa GW, Knutson WH, Bearden JD 3rd, Kottschade L, Fitch TR. Loprinzi CL, et al. Among authors: atherton pj. Ann Oncol. 2009 Mar;20(3):542-9. doi: 10.1093/annonc/mdn644. Epub 2009 Jan 6. Ann Oncol. 2009. PMID: 19129205 Free PMC article. Clinical Trial.
Limited sampling models for CPT-11, SN-38, and SN-38 glucuronide.
Sloan JA, Atherton P, Reid J, Pitot HC, Erlichman C, Schaaf L. Sloan JA, et al. Among authors: atherton p. Cancer Chemother Pharmacol. 2001 Sep;48(3):241-9. doi: 10.1007/s002800100296. Cancer Chemother Pharmacol. 2001. PMID: 11592347 Clinical Trial.
A phase I study of sequential irinotecan and 5-fluorouracil/leucovorin.
Goldberg RM, Kaufmann SH, Atherton P, Sloan JA, Adjei AA, Pitot HC, Alberts SR, Rubin J, Miller LL, Erlichman C. Goldberg RM, et al. Among authors: atherton p. Ann Oncol. 2002 Oct;13(10):1674-80. doi: 10.1093/annonc/mdf260. Ann Oncol. 2002. PMID: 12377659 Free article. Clinical Trial.
Phase I study of the matrix metalloproteinase inhibitor, BAY 12-9566.
Erlichman C, Adjei AA, Alberts SR, Sloan JA, Goldberg RM, Pitot HC, Rubin J, Atherton PJ, Klee GG, Humphrey R. Erlichman C, et al. Among authors: atherton pj. Ann Oncol. 2001 Mar;12(3):389-95. doi: 10.1023/a:1011183905848. Ann Oncol. 2001. PMID: 11332153 Free article. Clinical Trial.
409 results